Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 369

The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.

Respiratory mucosal immunity against SARS-CoV-2 after mRNA vaccination

Open access
Tang, Jinyi, Zeng, Cong, Cox, Thomas M., Li, Chaofan, Son, Young Min, Cheon, In Su, Wu, Yue, Behl, Supriya, Taylor, Justin J., Chakaraborty, Rana, Johnson, Aaron J., Shiavo, Dante N., Utz, James P., Reisenauer, Janani S., Midthun, David E., Mullon, John J., Edell, Eric S., Alameh, Mohamad G., Borish, Larry, Teague, William G., Kaplan, Mark H., Weissman, Drew, Kern, Ryan, Hu, Haitao, Vassallo, Robert, Liu, Shan-Lu, Sun, Jie·2022·Science Immunology

Abstract

SARS-CoV-2 mRNA vaccination induces robust humoral and cellular immunity in the circulation; however, it is currently unknown whether it elicits effective immune responses in the respiratory tract, particularly against variants of concern (VOCs), including Omicron. We compared the SARS-CoV-2 S–specific total and neutralizing antibody responses, and B and T cell immunity, in the bronchoalveolar lavage fluid (BAL) and blood of COVID-19–vaccinated individuals and hospitalized patients. Vaccinated individuals had significantly lower levels of neutralizing antibody against D614G, Delta (B.1.617.2), and Omicron BA.1.1 in the BAL compared with COVID-19 convalescents despite robust S-specific antibody responses in the blood. Furthermore, mRNA vaccination induced circulating S-specific B and T cell immunity, but in contrast to COVID-19 convalescents, these responses were absent in the BAL of vaccinated individuals. Using a mouse immunization model, we demonstrated that systemic mRNA vaccination alone induced weak respiratory mucosal neutralizing antibody responses, especially against SARS-CoV-2 Omicron BA.1.1 in mice; however, a combination of systemic mRNA vaccination plus mucosal adenovirus-S immunization induced strong neutralizing antibody responses not only against the ancestral virus but also the Omicron BA.1.1 variant. Together, our study supports the contention that the current COVID-19 vaccines are highly effective against severe disease development, likely through recruiting circulating B and T cell responses during reinfection, but offer limited protection against breakthrough infection, especially by the Omicron sublineage. Hence, mucosal booster vaccination is needed to establish robust sterilizing immunity in the respiratory tract against SARS-CoV-2, including infection by the Omicron sublineage and future VOCs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/sciimmunol.add4853

Cites

67 of 67 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 67 references

Cited by

See all 369

Metadata

Authors
Tang, J., Zeng, C., Cox, T. M., Li, C., Son, Y. M., Cheon, I. S., Wu, Y., Behl, S., Taylor, J. J., Chakaraborty, R., Johnson, A. J., Shiavo, D. N., Utz, J. P., Reisenauer, J. S., Midthun, D. E., Mullon, J. J., Edell, E. S., Alameh, M. G., Borish, L., Teague, W. G., Kaplan, M. H., Weissman, D., Kern, R., Hu, H., Vassallo, R., Liu, S.-L., & Sun, J.
Venue
Science Immunology
Published
2022-10-28
Volume
7
Issue
76
Pages
eadd4853-eadd4853
ISSN
2470-9468 (ISSN-L)
OpenAlex
W4286217721
Cited by
369
References
67
FWCI
36.18
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Respiratory mucosal immunity against SARS-CoV-2 after mRNA vaccination. https://app.cochat.ai/papers/10.1126/sciimmunol.add4853
The paper
Tang, J., Zeng, C., Cox, T. M., Li, C., Son, Y. M., Cheon, I. S., Wu, Y., Behl, S., Taylor, J. J., Chakaraborty, R., Johnson, A. J., Shiavo, D. N., Utz, J. P., Reisenauer, J. S., Midthun, D. E., Mullon, J. J., Edell, E. S., Alameh, M. G., Borish, L., . . . Sun, J. (2022). Respiratory mucosal immunity against SARS-CoV-2 after mRNA vaccination. Science Immunology. https://doi.org/10.1126/sciimmunol.add4853

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.